|
|
Volumn 29, Issue SUPPL. 1, 1996, Pages 40-48
|
|
Rationale for the inclusion of alpha-adrenergic blockade in benign prostatic hyperplasia treatment guidelines
|
|
Author keywords
Alpha blocker; Benign prostatic hyperplasia; Treatment guidelines
|
|
Indexed keywords
ADRENERGIC RECEPTOR BLOCKING AGENT;
ASTHENIA;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DROWSINESS;
DRUG EFFICACY;
DRUG SAFETY;
HEADACHE;
HEART PALPITATION;
HUMAN;
IMPOTENCE;
MALE;
MULTICENTER STUDY;
ORTHOSTATIC HYPOTENSION;
PATIENT COMPLIANCE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROSTATE HYPERTROPHY;
RANDOMIZED CONTROLLED TRIAL;
TACHYCARDIA;
TREATMENT FAILURE;
VERTIGO;
|
|
EID: 0029925552
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000473819 Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
